Interestingly, a previous study reported that the levels of PPARγ are decreased in both patients with active UC and CD patients36, while TLR4 expression was significantly increased in IBD patients, specifically in patients with active UC35,36,50. Here, PPARG is linked to inflammatory bowel disease.